SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-005902
Filing Date
2021-05-05
Accepted
2021-05-05 16:02:03
Documents
14
Period of Report
2021-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20210505x8k.htm   iXBRL 8-K 44684
2 EX-99.1 xncr-20210505xex99d1.htm EX-99.1 178628
3 GRAPHIC xncr-20210505xex99d1001.jpg GRAPHIC 5434
  Complete submission text file 0001558370-21-005902.txt   362484

Data Files

Seq Description Document Type Size
4 EX-101.SCH xncr-20210505.xsd EX-101.SCH 2973
5 EX-101.LAB xncr-20210505_lab.xml EX-101.LAB 15408
6 EX-101.PRE xncr-20210505_pre.xml EX-101.PRE 9957
7 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20210505x8k_htm.xml XML 4622
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 21893111
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences